A Pim kinase inhibitor compound having the structure represented by Formula I, and isomers, diastereomers, enantiomers, tautomers, and pharmaceutically acceptable salts thereof. The compounds significantly inhibit Pim kinase activity and can be used to prepare drugs for treating Pim kinase mediated diseases, such as cancers, autoimmune diseases, allergic reactions, or organ transplant rejection. Also provided are methods for preparing the compounds represented by Formula I.
一种具有公式I所表示的结构的Pim激酶
抑制剂化合物,以及其异构体、对映异构体、对映体、互变异构体和药学上可接受的盐。该化合物显著抑制Pim激酶活性,并可用于制备用于治疗Pim激酶介导的疾病,如癌症、自身免疫疾病、过敏反应或器官移植排斥的药物。还提供了制备公式I所表示的化合物的方法。